CompletedPhase 1NCT00816426

Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis

Studying Tuberculosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Principal Investigator
Clifton E Barry, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Intervention
Rifampicin(drug)
Enrollment
19 enrolled
Eligibility
20-100 years · All sexes
Timeline
2008 – 2017

Study locations (3)

Collaborators

Korean Center for Disease Control and Prevention · International Tuberculosis Research Center · Novartis Institute for Tropical Medicine · Asian Medical Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00816426 on ClinicalTrials.gov

Other trials for Tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Tuberculosis →

← Back to all trials